158 related articles for article (PubMed ID: 9988824)
1. Nuchal thickness, urine beta-core fragment level, and maternal age for down syndrome screening.
Bahado-Singh RO; Oz AU; Flores D; Cermik D; Acuna E; Mahoney MJ; Cole L
Am J Obstet Gynecol; 1999 Feb; 180(2 Pt 1):491-5. PubMed ID: 9988824
[TBL] [Abstract][Full Text] [Related]
2. A high-sensitivity alternative to "routine" genetic amniocentesis: multiple urinary analytes, nuchal thickness, and age.
Bahado-Singh R; Oz U; Kovanci E; Cermik D; Copel J; Mahoney MJ; Cole L
Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):169-73. PubMed ID: 9914599
[TBL] [Abstract][Full Text] [Related]
3. Elevated maternal urine level of beta-core fragment of human chorionic gonadotropin versus serum triple test in the second-trimester detection of down syndrome.
Bahado-Singh R; Oz U; Rinne K; Hunter D; Cole L; Mahoney MJ; Baumgarten A
Am J Obstet Gynecol; 1999 Oct; 181(4):929-33. PubMed ID: 10521756
[TBL] [Abstract][Full Text] [Related]
4. The comprehensive midtrimester test: high-sensitivity Down syndrome test.
Bahado-Singh R; Shahabi S; Karaca M; Mahoney MJ; Cole L; Oz UA
Am J Obstet Gynecol; 2002 Apr; 186(4):803-8. PubMed ID: 11967511
[TBL] [Abstract][Full Text] [Related]
5. A new screening protocol combining urine beta-core fragment and ultrasonography for Down syndrome detection.
Bahado-Singh RO; Oz UA; Deren O; Acuna E; Cermik D; Mahoney MJ; Cole L
Am J Obstet Gynecol; 1998 Apr; 178(4):779-82. PubMed ID: 9579443
[TBL] [Abstract][Full Text] [Related]
6. New Down syndrome screening algorithm: ultrasonographic biometry and multiple serum markers combined with maternal age.
Bahado-Singh RO; Oz AU; Kovanci E; Deren O; Copel J; Baumgarten A; Mahoney J
Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 1):1627-31. PubMed ID: 9855608
[TBL] [Abstract][Full Text] [Related]
7. Ratio of nuchal thickness to humerus length for Down syndrome detection.
Bahado-Singh RO; Oz U; Hsu CD; Deren O; Copel JA; Mahoney MJ
Am J Obstet Gynecol; 2001 May; 184(6):1284-8. PubMed ID: 11349203
[TBL] [Abstract][Full Text] [Related]
8. Normal nuchal thickness in the midtrimester indicates reduced risk of Down syndrome in pregnancies with abnormal triple-screen results.
Bahado-Singh RO; Goldstein I; Uerpairojkit B; Copel JA; Mahoney MJ; Baumgarten A
Am J Obstet Gynecol; 1995 Oct; 173(4):1106-10. PubMed ID: 7485301
[TBL] [Abstract][Full Text] [Related]
9. Gestational age standardized nuchal thickness values for estimating mid-trimester Down's syndrome risk.
Bahado-Singh RO; Oz UA; Kovanci E; Deren O; Feather M; Hsu CD; Copel JA; Mahoney MJ
J Matern Fetal Med; 1999; 8(2):37-43. PubMed ID: 10090488
[TBL] [Abstract][Full Text] [Related]
10. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
11. Critical appraisal of the use of nuchal fold thickness measurements for the prediction of Down syndrome.
Locatelli A; Piccoli MG; Vergani P; Mariani E; Ghidini A; Mariani S; Pezzullo JC
Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):192-7. PubMed ID: 10649178
[TBL] [Abstract][Full Text] [Related]
12. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Spencer K; Souter V; Tul N; Snijders R; Nicolaides KH
Ultrasound Obstet Gynecol; 1999 Apr; 13(4):231-7. PubMed ID: 10341399
[TBL] [Abstract][Full Text] [Related]
13. Urinary screening tests for fetal Down syndrome: I. Fresh beta-core fragment.
Cole LA; Rinne KM; Mahajan SM; Oz UA; Shahabi S; Mahoney MJ; Bahado-Singh RO
Prenat Diagn; 1999 Apr; 19(4):340-50. PubMed ID: 10327140
[TBL] [Abstract][Full Text] [Related]
14. Urine hyperglycosylated hCG plus ultrasound biometry for detection of down syndrome in the second trimester in a high-risk population.
Bahado-Singh R; Oz U; Shahabi S; Omrani A; Mahoney M; Cole L
Obstet Gynecol; 2000 Jun; 95(6 Pt 1):889-94. PubMed ID: 10831986
[TBL] [Abstract][Full Text] [Related]
15. Comparison and integration of first trimester fetal nuchal translucency and second trimester maternal serum screening for fetal Down syndrome.
Lam YH; Lee CP; Sin SY; Tang R; Wong HS; Wong SF; Fong DY; Tang MH; Woo HH
Prenat Diagn; 2002 Aug; 22(8):730-5. PubMed ID: 12210586
[TBL] [Abstract][Full Text] [Related]
16. Screening for Down syndrome pregnancy using beta-core fragment: prospective study.
Isozaki T; Palomaki GE; Bahado-Singh RO; Cole LA
Prenat Diagn; 1997 May; 17(5):407-13. PubMed ID: 9178314
[TBL] [Abstract][Full Text] [Related]
17. New triple screen test for Down syndrome: combined urine analytes and serum AFP.
Bahado-Singh RO; Oz U; Kovanci E; Cermik D; Flores D; Copel J; Mahoney M; Cole L
J Matern Fetal Med; 1998; 7(3):111-4. PubMed ID: 9642606
[TBL] [Abstract][Full Text] [Related]
18. Combining beta-core fragment and total oestriol measurements to test for Down syndrome pregnancies.
Cole LA; Acuna E; Isozaki T; Palomaki GE; Bahado-Singh RO; Mahoney MO
Prenat Diagn; 1997 Dec; 17(12):1125-33. PubMed ID: 9467809
[TBL] [Abstract][Full Text] [Related]
19. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
Audibert F; Gagnon A; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
[TBL] [Abstract][Full Text] [Related]
20. Maternal urine beta-core hCG fragment level and small for gestational age neonates.
Bahado-Singh R; Oz U; Flores D; Hsu C; Mari G; Cole L
Obstet Gynecol; 2000 May; 95(5):662-6. PubMed ID: 10775725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
